A streamlined platform for high-content functional proteomics of primary human specimens

Nature Methods

Volumn 2, Issue 9, 2005, Pages 691-697

  Jessani, Nadim ^a,d   Niessen, Sherry ^a   Wei, BinQing Q ^a   Nicolau, Monica ^b   Humphrey, Mark ^a   Ji, Youngran ^b   Han, Wonshik ^c   Noh, Dong Young ^c   Yates III, John R ^a   Jeffrey, Stefanie S ^b   Cravatt, Benjamin F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Seoul National University College of Medicine   (South Korea)

^d CELERA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR;

ARTICLE; BREAST TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DNA MICROARRAY; ENZYME ACTIVITY; FUNCTIONAL PROTEOMICS; GEL ELECTROPHORESIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; TUMOR BIOPSY; TUMOR CLASSIFICATION;

BREAST NEOPLASMS; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM PROTEINS; PROTEOME; PROTEOMICS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 24044520992     PISSN: 15487091     EISSN: None     Source Type: Journal    
DOI: 10.1038/nmeth778     Document Type: Article

References (39)

1. Kramer, R. & Cohen, D. Functional genomics to new drug targets. Nat. Rev. Drug Discov. 3, 965-972 (2004).
2. Patterson, S.D. & Aebersold, R. Proteomics: the first decade and beyond. Nat. Genet. 33, 311-323 (2003).
3. Patton, W.F., Schulenberg, B. & Steinberg, T.H. Two-dimensional electrophoresis: better than a poke in the ICAT? Curr. Opin. Biotechnol. 13, 321-328 (2002).
4. Gygi, S.P. et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17, 994-999 (1999).
5. Washburn, M.P., Wolters, D. & Yates, JR, III. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19, 242-247 (2001).
6. Chaurand, P., Sanders, M.E., Jensen, R.A. & Caprioli, R.M. Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections. Am. J. Pathol. 165, 1057-1068 (2004).
7. Petricoin, E.F. & Liotta, L.A. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr. Opin. Biotechnol. 15, 24-30 (2004).
8. Durr, E. et al. Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat. Biotechnol. 22, 985-992 (2004).
9. Gygi, S.P., Rist, B., Griffin, T.J., Eng, J. & Aebersold, R. Proteome analysis of low-abundance proteins using multidimensional chromatography and isotope-coded affinity tags. J. Proteome Res. 1, 47-54 (2002).
10. Kobe, B. & Kemp, B.E. Active site-directed protein regulation. Nature 402, 373-376 (1999).
11. Zangar, R.C., Varnum, S.M., Covington, C.Y. & Smith, R.D. A rational approach for discovering and validating cancer markers in very small samples using mass spectrometry and ELISA microarrays. Dis. Markers 20, 135-148 (2004).
12. Jessani, N. & Cravatt, B.F. The development and application of methods for activity-based protein profiling. Curr. Opin. Chem. Biol. 8, 54-59 (2004).
13. Speers, A.E. & Cravatt, B.F. Chemical strategies for activity-based proteomics. ChemBioChem. 5, 41-47 (2004).
14. Jessani, N., Liu, Y., Humphrey, M. & Cravatt, B.F. Enzyme activity profiles of the secreted and membrane proteome that depict cancer invasiveness. Proc. Natl. Acad. Sci. USA 99, 10335-10340 (2002).
15. Jessani, N. et al. Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo. Proc. Natl. Acad. Sci. USA 101, 13756-13761 (2004).
16. Pang, J.X., Ginanni, N., Dongre, A.R., Hefta, S.A. & Opitek, G.J. Biomarker discovery in urine by proteomics. J. Proteome Res. 1, 161-169 (2002).
17. Liu, H., Sadygov, R.G. & Yates, J.R., III. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 76, 4193-4201 (2004).
18. Liu, Y., Patricelli, M.P. & Cravatt, B.F. Activity-based protein profiling: the serine hydrolases. Proc. Natl. Acad. Sci. USA 96, 14694-14699 (1999).
19. Andreasen, P.A., Kjoller, L., Christensen, L. & Duffy, M.J. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72, 1-22 (1997).
20. Huang, Y., Wang, S. & Kelly, T. Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer. Cancer Res. 64, 2712-2716 (2004).
21. Gallardo-Williams, M.T., Maronpot, R.R., Wine, R.N., Brunssen, S.H. & Chapin, R.E. Inhibition of the enzymatic activity of prostate-specific antigen by boric acid and 3-nitrophenyl boronic acid. Prostate 54, 44-49 (2003).
22. Okerberg, E.S. et al. High-resolution functional proteomics by active-site peptide profiling. Proc. Natl. Acad. Sci. USA 102, 4996-5001 (2005).
23. Chen, W.T., Kelly, T. & Ghersi, G. DPPIV, seprase, and related serine peptidases in multiple cellular functions. Curr. Top. Dev. Biol. 54, 207-232 (2003).
24. Arai, H. Platelet-activating factor acetylhydrolase. Prostaglandins Other Lipid Mediat. 68-69, 83-94 (2002).
25. Sorlie, T. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98, 10869-10874 (2001).
26. Huber, M.A. et al. Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors. J. Invest. Dermatol. 120, 182-188 (2003).
27. Scanlan, M.J. et al. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc. Natl. Acad. Sci. USA 91, 5657-5661 (1994).
28. Kelly, T., Kechelava, S., Rozypal, T.L., West, K.W. & Korourian, S. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers. Mod. Pathol. 11, 855-863 (1998).
29. Leung, D., Hardouin, C., Boger, D.L. & Cravatt, B.F. Discovering potent and selective reversible inhibitors of enzymes in complex proteomes. Nat. Biotechnol. 21, 687-691 (2003).
30. Sieber, S.A., Mondala, T.S., Head, S.R. & Cravatt, B.F. Microarray platform for profiling enzyme activities in complex proteomes. J. Am. Chem. Soc. 126, 15640-15641 (2004).
31. Adam, G.C., Sorensen, E.J. & Cravatt, B.F. Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype. Nat. Biotechnol. 20, 805-809 (2002).
32. Greenbaum, D. et al. Chemical approaches for functionally probing the proteome. Mol. Cell. Proteomics 1, 60-68 (2002).
33. Barglow, K.T. & Cravatt, B.F. Discovering disease-associated enzymes by proteome reactivity profiling. Chem. Biol. 11, 1523-1531 (2004).
34. Saghatelian, A., Jessani, N., Joseph, A., Humphrey, M. & Cravatt, B.F. Activity-based probes for the proteomic profiling of metalloproteases. Proc. Natl. Acad. Sci. USA 101, 10000-10005 (2004).
35. Chan, E.W., Chattopadhaya, S., Panicker, R.C., Huang, X. & Yao, S.Q. Developing photoactive affinity probes for proteomic profiling: hydroxamate-based probes for metalloproteases. J. Am. Chem. Soc. 126, 14435-14446 (2004).
36. Liu, Y. et al. Wortmannin, a widely used phosphoinositide 3-kinase inhibitor, also potently inhibits mammalian polo-like kinase. Chem. Biol. 12, 99-107 (2005).
37. Eisen, M.B., Spellman, P.T., Brown, P.O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863-14868 (1998).
38. Kidd, D., Liu, Y. & Cravatt, B.F. Profiling serine hydrolase activities in complex proteomes. Biochemistry 40, 4005-4015 (2001).
39. Zhao, H. et al. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol. Biol. Cell 15, 2523-2536 (2004).